Aromatic compounds
    102.
    发明授权
    Aromatic compounds 失效
    芳香族化合物

    公开(公告)号:US5512596A

    公开(公告)日:1996-04-30

    申请号:US300607

    申请日:1994-09-02

    摘要: A composition comprising a compound of the formula: ##STR1## wherein: X is H or OH;Y is a group capable of hydrogen bonding to amino, guanidino, or imidazole function, or a group comprising an acidic hydrogen atom, a protected acidic group, or an anion;E is N or CR.sub.1, wherein R.sub.1 is H, OH, CN, F, Cl, Br, or I;A.sub.4, A.sub.5, and A.sub.6 are each independently N, CH, CR.sub.40 or CZ wherein R.sub.40 is R.sub.43, OR.sub.43, SR.sub.43, S(O)R.sub.43, S(O).sub.2 R.sub.43, or NR.sub.43 R.sub.44 wherein R.sub.43 comprises an alkyl of 1 to 3 carbon atoms, an acyl of 2 to 3 carbon atoms, or an alkyl of 1 to 3 carbon atoms substituted with an acyl of 2 to 3 carbon atoms, and R.sub.44 is H or an alkyl of 1 to 2 carbon atoms, and Z is a group capable of hydrogen bonding to carboxyl, or a group comprising a basic heteroatom, a protected basic heteroatom, or a cation.

    摘要翻译: 一种组合物,其包含下式化合物:其中:X为H或OH; Y是能够键合到氨基,胍基或咪唑官能团的基团,或包含酸性氢原子,被保护的酸性基团或阴离子的基团; E是N或CR1,其中R1是H,OH,CN,F,Cl,Br或I; A4,A5和A6各自独立地为N,CH,CR40或CZ,其中R40为R43,OR43,SR43,S(O)R43,S(O)2R43或NR43R44,其中R43包含1至3个碳原子的烷基 2〜3个碳原子的酰基,或被2〜3个碳原子的酰基取代的1〜3个碳原子的烷基,R44是H或1〜2个碳原子的烷基,Z是能够 与羧基键合的氢键,或包含碱性杂原子,受保护的碱性杂原子或阳离子的基团。

    4'-Substituted Carbovir And Abacavir-Derivatives As Well As Related Compounds With Hiv And Hcv Antiviral Activity
    109.
    发明申请
    4'-Substituted Carbovir And Abacavir-Derivatives As Well As Related Compounds With Hiv And Hcv Antiviral Activity 审中-公开
    4'-取代的卡博维尔和阿巴卡韦衍生物以及与Hiv和Hcv抗病毒活性相关的化合物

    公开(公告)号:US20080287471A1

    公开(公告)日:2008-11-20

    申请号:US10583573

    申请日:2004-12-22

    摘要: The application relates to compounds with activity against infectious viruses. Accordingly, in one embodiment the invention provides a compound of the invention which is a compound of Formula I: (I) wherein: B is adenine, guanine cytosine, uracil, thymine, 7-deazaadenine, 7-deazaguanine, 7-deaza-8-azaguanine, 7-deaza-8-azaadenine, inosine, nebularine, nitropyrrole, nitroindole, 2-aminopurine, 2-amino-6-chloropuriine, 2,6-diaminopurine, hypoxanthine, pseudouridine, pseudo-cytosine, pseudoisocytosine, 5-propynylcytosine, isocytosines, isoguanine, 7-deazaguanine, 2-thiopyrimidine, 6-thioguanine, 4-thiothymine, 4-thiouracil O6-methylguanine, N6-methyladenine, O4-methylthymine, 5,6-dihydrothymine, 5,6-dihydroucacil, 4-methylindole, triazole, or pyrazolo[3,4-d]pyrimidine; and B is optionally substituted with one or more alkyl, alkenyl, alkynyl, cycloalkyl, (cycloalkyl)alkyl, hydroxy, or halo; and R1 is alkyl, alkenyl, alkynyl, cyano, azido, or fluoromethyl; or a pharmaceutically acceptable salt or solvate thereof.

    摘要翻译: 本申请涉及具有抗感染性病毒活性的化合物。 因此,在一个实施方案中,本发明提供了本发明化合物,其为式I化合物:(I)其中:B为腺嘌呤,鸟嘌呤胞嘧啶,尿嘧啶,胸腺嘧啶,7-脱氮腺嘌呤,7-脱氮鸟嘌呤,7-脱氮-8 2-氮杂鸟嘌呤,7-脱氮-8-氮杂腺嘌呤,肌苷,星云碱,硝基吡咯,硝基吲哚,2-氨基嘌呤,2-氨基-6-氯嘌呤,2,6-二氨基嘌呤,次黄嘌呤,假尿苷,假胞嘧啶,假异胞嘧啶,5-丙炔基胞嘧啶 ,异胞嘧啶,异鸟嘌呤,7-脱氮鸟嘌呤,2-硫代嘧啶,6-硫鸟嘌呤,4-硫代胸腺嘧啶,4-硫尿嘧啶O 6 - 甲基鸟嘌呤,N 6 - 甲基腺嘌呤, 5,6-二氢胸腺嘧啶,5,6-二氢尿嘧啶,4-甲基吲哚,三唑或吡唑并[3,4-d]嘧啶; 并且B任选被一个或多个烷基,烯基,炔基,环烷基,(环烷基)烷基,羟基或卤素取代; R 1是烷基,烯基,炔基,氰基,叠氮基或氟甲基; 或其药学上可接受的盐或溶剂合物。

    Antiviral analogs
    110.
    发明授权
    Antiviral analogs 失效
    抗病毒类似物

    公开(公告)号:US07432272B2

    公开(公告)日:2008-10-07

    申请号:US11020641

    申请日:2004-12-22

    摘要: The application relates to 4′-substituted nucleoside derivatives of Formula I: wherein B and R1 have any of the values described in the application, as well as to compositions comprising such compounds, to methods and intermediates useful for preparing such compounds, and to therapeutic methods comprising administering such compounds to animals in need thereof.

    摘要翻译: 本申请涉及式I的4'-取代的核苷衍生物:其中B和R 1具有本申请中描述的任何值,以及包含这些化合物的组合物,对于有用的方法和中间体 以及用于治疗方法的方法,包括向有需要的动物施用此类化合物。